Intellia Therapeutics Inc... (NTLA)
NASDAQ: NTLA
· Real-Time Price · USD
10.99
0.09 (0.83%)
At close: Aug 15, 2025, 3:59 PM
11.01
0.18%
After-hours: Aug 15, 2025, 07:57 PM EDT
Intellia Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -480.19M | -525.91M | -519.02M | -522.28M | -508.8M | -485.5M | -481.19M | -462.44M | -453.44M | -430.44M | -474.19M | -442.02M | -400.43M | -368.56M | -267.89M | -228.85M | -185.04M | -148.63M |
Depreciation & Amortization | 10.15M | 10.27M | 10.29M | 10.19M | 9.87M | 9.44M | 8.98M | 8.54M | 8.2M | 7.87M | 7.57M | 7.42M | 7.26M | 7.05M | 6.89M | 6.61M | 6.43M | 6.36M |
Stock-Based Compensation | 123.11M | 141.94M | 154.27M | 149.7M | 145.43M | 140.97M | 134.05M | 123.63M | 113.5M | 100.16M | 91.4M | 81.33M | 71.53M | 59.08M | 47.01M | 38.03M | 28.02M | 22.17M |
Other Working Capital | -59.1M | -42.46M | -22.86M | 6.01M | -14.8M | -29.33M | -30.93M | -74.49M | -82.34M | -80.53M | -61.34M | -61.29M | -50.45M | -43.54M | -31.36M | -22.67M | -37.93M | 42.71M |
Other Non-Cash Items | -4.97M | 13.74M | -6.29M | -14.44M | -12.18M | -25.04M | -3.47M | 15.5M | 25.22M | 30.3M | 93.3M | 89.9M | 81.32M | 75.05M | 11.87M | 63.27M | 61.24M | 59.51M |
Deferred Income Tax | n/a | n/a | n/a | 7.16M | 3.08M | n/a | n/a | -7.16M | -3.08M | n/a | n/a | n/a | n/a | n/a | n/a | -57.53M | -57.53M | -57.53M |
Change in Working Capital | -66.67M | -17.18M | 11.88M | 12.95M | -10.68M | -45.28M | -52.45M | -68.98M | -60.93M | -73.2M | -53.87M | -37.2M | -44.24M | -25.08M | -22.9M | -32.14M | -27.26M | 54.37M |
Operating Cash Flow | -418.58M | -377.15M | -348.88M | -356.74M | -373.28M | -405.42M | -394.09M | -390.9M | -368.05M | -362.81M | -333.29M | -298.07M | -284.56M | -252.46M | -225.03M | -210.6M | -174.14M | -63.74M |
Capital Expenditures | -3.23M | -4.01M | -5.78M | -6.32M | -9.37M | -12.66M | -13.98M | -16.38M | -16.28M | -15.96M | -58.39M | -57.35M | -57.65M | -56.6M | -12.76M | -10.89M | -7.05M | -5.15M |
Cash Acquisitions | n/a | n/a | n/a | -47.46M | -131.29M | -101.05M | 17.36M | 121.06M | 204.89M | 75.33M | -43.09M | -99.33M | -99.33M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -514.01M | -759.22M | -935.57M | -916.25M | -839.51M | -781.99M | -904.46M | -991.12M | -1.02B | -811.07M | -429.03M | -440.46M | -866.71M | -872.29M | -1.02B | -1B | -627.92M | -590.83M |
Sales Maturities Of Investments | 841.38M | 956.26M | 1.05B | 921.54M | 956.03M | 891.45M | 887.1M | 900.06M | 899.66M | 817.46M | 647.58M | 532M | 511.68M | 454.13M | 485.6M | 409.98M | 277.8M | 298.5M |
Other Investing Acitivies | 20.97M | 20.97M | 20.97M | 68.43M | 131.29M | 101.05M | -17.36M | -121.06M | -153.01M | -23.45M | 50.14M | 103.37M | -343.35M | -406.48M | -384.77M | -591.69M | -350.13M | -292.32M |
Investing Cash Flow | 345.09M | 213.99M | 125.57M | 19.94M | 107.15M | 96.8M | -31.35M | -107.44M | -139.29M | -9.41M | 160.31M | 31.35M | -415.68M | -477.76M | -550.78M | -602.58M | -357.18M | -297.48M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.93M | 4.54M | 6.5M | 9.37M | 12.06M | 11.73M | 10.53M | 9.77M | 6.11M | 9.49M | 17.17M | 17.33M | 36.98M | 38.21M | 43.12M | 51.32M | 31.55M | 26.14M |
Financial Cash Flow | 99.16M | 125.75M | 185.75M | 289.91M | 226.82M | 188.09M | 130.32M | 529.6M | 534.48M | 537.86M | 582.96M | 79.47M | 724.17M | 725.41M | 736.69M | 968.5M | 300.42M | 425.51M |
Net Cash Flow | 25.67M | -37.4M | -37.57M | -46.88M | -39.31M | -120.52M | -295.11M | 31.26M | 27.14M | 165.63M | 409.98M | -187.25M | 23.93M | -4.8M | -39.12M | 155.31M | -230.9M | 64.29M |
Free Cash Flow | -421.82M | -381.15M | -354.66M | -363.06M | -382.65M | -418.08M | -408.07M | -407.28M | -384.33M | -378.77M | -391.68M | -355.42M | -342.21M | -309.06M | -237.79M | -221.5M | -181.19M | -68.89M |